GNW
RLI
ACT

RESTREPO ROBERT P JR

Known title: DirectorCIK: 0001227758

RESTREPO ROBERT P JR's purchase track record

RESTREPO ROBERT P JR has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
2/4/2022GNW$197K+2.5%+6.8%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

KBW Downgrades Genworth to Market Perform, Cuts Price Target. Keefe, Bruyette & Woods downgraded Genworth Financial to Market Perform from Outperform, lowering its price target to $10.50. The firm cited Voya Financial as a key reason for the reduced outlook. The stock is currently trading near its 52-week high, with an average analyst target of $11.50.

this person other insiders at GNW

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

RLI Corp. Releases Q3 Earnings Amid Mixed Analyst Views. RLI Corp. recently released its third-quarter earnings and held a teleconference to discuss results. While recent articles highlight the company's long dividend history, other reports suggest some investors are questioning its current valuation. The stock is currently trading near its 52-week low, with an average analyst target price of $59.00, indicating a range of expectations for future performance.

this person other insiders at RLI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

Enact Holdings Reports Q2 Earnings and Reinsurance Deal. Enact Holdings released its Q2 2026 earnings results and announced a new forward quota share reinsurance transaction to diversify credit risk. The company also received affirmed credit ratings from AM Best. These developments provide context for the stock's current valuation, which sits below the average analyst target price.

this person other insiders at ACT

Transaction History

GNW▼ Sell$456K
GNW▲ Buy$165K
RLI▲ Buy$0
RLI▼ Sell$0
ACT▼ Sell$215K
ACT▼ Sell$278K
ACT▼ Sell$96K
ACT▼ Sell$347K
GNW▲ Buy$165K
RLI▲ Buy$0
RLI▼ Sell$0
RLI▼ Sell$214K
GNW▲ Buy$150K
RLI▲ Buy$0
RLI▼ Sell$0
GNW▲ Buy$150K
RLI▲ Buy$0
RLI▼ Sell$0
RLI▲ Buy$0
RLI▼ Sell$0
GNW▲ Buy$197K

We use analytics to understand how market-wall is used. No personal data is sold.